Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapivirine Ring and Clotrimazole Interaction Study
NCT02847286Phase 1Completed
- Sponsor
- International Partnership for Microbicides
- Start
- Sep 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of dapivirine in human immunodeficiency virus infection (HIV) (3 arms), sponsored by International Partnership for Microbicides. Primary endpoints: Dapivirine concentrations in plasma at 28 days and Clotrimazole concentrations in plasma. Started Sep 2015; status: completed.
02
Drugs
dapivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02847286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02847286.